Clinical Library · Hormonal Health
How to manage PCOS naturally with inositol — India guide
PCOS affects roughly 1 in 5 Indian women of reproductive age. At its core, it's an insulin-signalling problem: cells stop responding to insulin, insulin rises, ovaries make more androgens, and cycles slip. Inositol addresses the signalling problem directly — and it does so with a side-effect profile close to zero.
What inositol actually does
Inositol is a B-vitamin-like molecule your body uses as a second messenger for insulin. In PCOS, that messenger system runs low. Supplementation restores it — cells hear insulin again, blood sugar and insulin drop, ovarian androgen production settles, and cycles slowly normalise.
The 40:1 myo:D-chiro ratio — why it matters
Healthy human plasma sits at roughly 40:1 myo-inositol to D-chiro-inositol. The RCTs with the best PCOS outcomes — cycle regularity, ovulation, lower fasting insulin — used this ratio. Higher D-chiro ratios (1:1, 2:1) have actually worsened egg quality in some studies. If you take one thing from this article: the ratio is not marketing, it's biology.
Dose, timing, and what to expect
- Dose: 2000 mg myo-inositol + 50 mg D-chiro-inositol, twice daily (total ~4 g myo + 100 mg D-chiro).
- Timing: With breakfast and dinner. Split doses maintain blood levels better than a single big dose.
- Week 1–4: Sugar cravings drop, energy steadies.
- Month 2–3: Fasting insulin drops in labs; skin starts clearing; cycle begins to shorten if it was long.
- Month 4–6: Cycle regularity, mood stability, easier weight loss. Ovulation returns in a majority of anovulatory patients.
- Safety: Well-tolerated even in pregnancy (used in some gestational diabetes trials). Occasional GI upset at very high doses.
What to pair with inositol
Berberine HCl
AMPK activator with metformin-like effects on insulin, lipids and androgens. Excellent complement in PCOS with high fasting insulin.
L-5-MTHF (active folate)
Standard folic acid has to be converted — many Indian women carry MTHFR variants that make this inefficient. Quatrefolic® / L-5-MTHF skips the step.
Vitamin D3
Very common Indian deficiency; low D is associated with worse insulin sensitivity in PCOS. Retest and dose to a 25-OH-D of 40–60 ng/mL.
Magnesium bisglycinate
Improves insulin signalling, sleep and PMS. Almost everyone with PCOS runs low.
Omega-3 (EPA/DHA)
Lowers triglycerides and androgens; improves acne. Aim for 1–2 g/day of EPA+DHA.
Lifestyle that amplifies everything
- Strength train 3× / week. Muscle is the biggest insulin-sensitive tissue. Nothing else moves fasting insulin faster.
- Protein at every meal. 25–35 g. Blunts glucose spikes and controls cravings.
- Sleep 7.5+ hours. One poor night raises insulin resistance by ~30% the next day. Non-negotiable.
- Cap alcohol at 2 drinks / week. Alcohol raises androgens and worsens insulin signalling.
Ova Balance — 40:1 inositol + berberine + active folate
Ova Balance is a single-sachet daily protocol: 40:1 myo:D-chiro-inositol, berberine HCl and Quatrefolic® L-5-MTHF at research-backed doses. The exact combination the trials use, without stacking three bottles.
References
Every in-text claim in this article is credited to the original researchers and peer-reviewed journal below. Key studies cited: Unfer V et al. (2017, Endocrine Connections); Nordio M et al. (2012, European Review for Medical and Pharmacological Sciences); Facchinetti F et al. (2015, European Journal of Obstetrics & Gynecology and Reproductive Biology).
- [1]
Myo-inositol effects in women with PCOS: a meta-analysis of randomized controlled trials
- Author(s)
- Unfer V, Facchinetti F, Orrù B, Giordani B, Nestler J
- Year
- 2017
- Journal
- Endocrine Connections
- Citation
- Unfer V, Facchinetti F, Orrù B, Giordani B, Nestler J. Myo-inositol effects in women with PCOS: a meta-analysis of randomized controlled trials. Endocr Connect. 2017;6(8):647–658.
- PubMed
- https://pubmed.ncbi.nlm.nih.gov/29042448/
- [2]
The combined therapy with myo-inositol and D-chiro-inositol reduces the risk of metabolic disease in PCOS overweight patients compared to myo-inositol supplementation alone
- Author(s)
- Nordio M, Proietti E
- Year
- 2012
- Journal
- European Review for Medical and Pharmacological Sciences
- Citation
- Nordio M, Proietti E. The combined therapy with myo-inositol and D-chiro-inositol reduces the risk of metabolic disease in PCOS overweight patients compared to myo-inositol supplementation alone. Eur Rev Med Pharmacol Sci. 2012;16(5):575–581.
- PubMed
- https://pubmed.ncbi.nlm.nih.gov/22774396/
- [3]
Results from the International Consensus Conference on myo-inositol and d-chiro-inositol in obstetrics and gynecology
- Author(s)
- Facchinetti F, Bizzarri M, Benvenga S, D'Anna R, Lanzone A, Soulage C, et al.
- Year
- 2015
- Journal
- European Journal of Obstetrics & Gynecology and Reproductive Biology
- Citation
- Facchinetti F, Bizzarri M, Benvenga S, et al. Results from the International Consensus Conference on myo-inositol and d-chiro-inositol in obstetrics and gynecology. Eur J Obstet Gynecol Reprod Biol. 2015;195:72–76.
- PubMed
- https://pubmed.ncbi.nlm.nih.gov/26479442/
Citations follow AMA format. TruWe does not own or endorse the linked journals; all rights and credit remain with the original authors and their respective publishers.
Educational only. If you are trying to conceive, pregnant, or on metformin or oral contraceptives, discuss inositol with your gynaecologist first.
